406 related articles for article (PubMed ID: 27865389)
21. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
[TBL] [Abstract][Full Text] [Related]
22. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
23. Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis.
Kumar S; Bhaskar A; Patnaik G; Sharma C; Singh DK; Kaushik SR; Chaturvedi S; Das G; Dwivedi VP
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33444288
[TBL] [Abstract][Full Text] [Related]
24. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
25. Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.
Nangpal P; Bahal RK; Tyagi AK
Sci Rep; 2017 Dec; 7(1):17286. PubMed ID: 29230061
[TBL] [Abstract][Full Text] [Related]
26. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
28. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.
Santosuosso M; McCormick S; Zhang X; Zganiacz A; Xing Z
Infect Immun; 2006 Aug; 74(8):4634-43. PubMed ID: 16861651
[TBL] [Abstract][Full Text] [Related]
29. Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs.
Dey B; Jain R; Khera A; Rao V; Dhar N; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
Vaccine; 2009 Dec; 28(1):63-70. PubMed ID: 19835824
[TBL] [Abstract][Full Text] [Related]
30. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
[TBL] [Abstract][Full Text] [Related]
31. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
32. Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
Haile M; Hamasur B; Jaxmar T; Gavier-Widen D; Chambers MA; Sanchez B; Schröder U; Källenius G; Svenson SB; Pawlowski A
Tuberculosis (Edinb); 2005; 85(1-2):107-14. PubMed ID: 15687034
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
[TBL] [Abstract][Full Text] [Related]
34. Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis.
Tirado Y; Puig A; Alvarez N; Borrero R; Aguilar A; Camacho F; Reyes F; Fernández S; Pérez JL; Espinoza DM; Payán JA; Sarmiento ME; Norazmi MN; Hernández-Pando R; Acosta A
Hum Vaccin Immunother; 2015; 11(3):657-61. PubMed ID: 25671612
[TBL] [Abstract][Full Text] [Related]
35. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
[TBL] [Abstract][Full Text] [Related]
36. Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model.
Kwon KW; Lee A; Larsen SE; Baldwin SL; Coler RN; Reed SG; Cho SN; Ha SJ; Shin SJ
Sci Rep; 2019 Oct; 9(1):15560. PubMed ID: 31664157
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
38. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
Horvath CN; Xing Z
Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
[TBL] [Abstract][Full Text] [Related]
39. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
40. Prolonged intervals during Mycobacterium tuberculosis subunit vaccine boosting contributes to eliciting immunity mediated by central memory-like T cells.
Bai C; He J; Niu H; Hu L; Luo Y; Liu X; Peng L; Zhu B
Tuberculosis (Edinb); 2018 May; 110():104-111. PubMed ID: 29779765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
